Document is current
Any future updates will be listed below
-
Authors
Byrne, H. L. http://orcid.org/0000-0001-7023-7976
Le Duc, G.
Lux, F.
Tillement, O.
Holmes, N. M.
James, A.
Jelen, U.
Dong, B.
Liney, G.
Roberts, T. L.
Kuncic, Z.
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council - Australia (APP1132471)
Cancer Institute NSW
- License Information
-
More Information
Article History
Received: 2 July 2020
Accepted: 23 September 2020
First Online: 6 October 2020
Ethics approval and consent to participate
: All animal experiments were approved by the Animal Care and Ethics committee of Western Sydney University (ACEC number A12431) and were conducted in accordance with the “Australian Code for the Care and Use of Animals for Scientific Purposes (2013)” and the “New South Wales Animal Research Act 1985”.
: Not applicable.
: FL and OT disclose the patent WO2011/135101. GLD and OT disclose the patent WO2009/053644. These patents protect the nanoparticles described in this publication: AGuIX<sup>®</sup>.
